![InvestingPro's Mid-Year Sale: Save up to 60% with Discount Code INVPRODEAL](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEJ6G08L_L.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.480 | 0.480 | 0.000 |
Stocks | 99.520 | 99.520 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.147 | 21.824 |
Price to Book | 3.259 | 4.011 |
Price to Sales | 2.621 | 2.265 |
Price to Cash Flow | 16.663 | 16.912 |
Dividend Yield | 1.726 | 1.338 |
5 Years Earnings Growth | 9.689 | 11.420 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 98.840 | 94.954 |
Consumer Cyclical | 1.160 | 9.092 |
Number of long holdings: 48
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 6.45 | 905.38 | -0.40% | |
Novo Nordisk B | DK0062498333 | 6.37 | 1,005.6 | +0.30% | |
Vertex | US92532F1003 | 3.58 | 468.72 | -0.80% | |
Amgen | US0311621009 | 3.41 | 312.45 | -0.40% | |
AstraZeneca | GB0009895292 | 3.25 | 12,356.0 | +0.23% | |
Regeneron Pharma | US75886F1075 | 3.21 | 1,051.27 | +0.04% | |
Stryker | US8636671013 | 3.13 | 340.25 | -0.09% | |
HCA | US40412C1018 | 3.12 | 321.28 | -6.41% | |
Thermo Fisher Scientific | US8835561023 | 2.98 | 553.00 | +0.40% | |
Merck&Co | US58933Y1055 | 2.80 | 123.77 | -4.66% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S-Asuntorahasto | 463.26M | 5.61 | -4.38 | - | ||
FIM Emerging markets ESG | 376.23M | -1.19 | -2.57 | 4.27 | ||
S SaastOrahasto Kohtuullinen | 286.82M | 5.82 | 3.59 | 5.88 | ||
S-Saastorahasto Rohkea | 251.52M | 8.56 | 6.47 | 8.40 | ||
FIM USA | 234.4M | 15.22 | 12.38 | 12.82 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review